Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study

Alexander Hein, Diether Lambrechts, Gunter Von Minckwitz, Lothar Häberle, Holger Eidtmann, Hans Tesch, Michael Untch, Jörn Hilfrich, Christian Schem, Mahdi Rezai, Bernd Gerber, Serban Dan Costa, Jens Uwe Blohmer, Kathrin Schwedler, Kornelia Kittel, Tanja Fehm, Georg Kunz, Matthias W. Beckmann, Arif B. Ekici, Claus HanuschJens Huober, Cornelia Liedtke, Christine Mau, Matthieu Moisse, Volkmar Müller, Valentina Nekljudova, Gilian Peuteman, Brigitte Rack, Matthias Rübner, Thomas Van Brussel, Liewei Wang, Richard M. Weinshilboum, Sibylle Loibl, Peter A. Fasching

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study'. Together they form a unique fingerprint.

Medicine & Life Sciences